FAKTOR-OPTIONSSCHEIN - EDWARDS LIFESCIENCES | Delayed Deutsche Boerse AG 03:40:37 07/06/2024 pm IST | ||
| 8.32 EUR | -1.77% |
|
| Current month | +6.14% | ||
| 1 month | +5.61% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 07/24/07 | 8.32 | -1.77% |
| 06/24/06 | 8.47 | +2.42% |
| 05/24/05 | 8.27 | -0.72% |
| 04/24/04 | 8.33 | -1.88% |
| 03/24/03 | 8.49 | +6.39% |
Delayed Quote Deutsche Boerse AG
Last update June 07, 2024 at 03:40 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Société Générale
|
| WKN | SV12D7 |
| ISIN | DE000SV12D71 |
| Date issued | 15/03/2023 |
| Strike | 76.77 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.05 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 15.77 € |
|---|---|
| Lowest since issue | 3.65 € |
| Spread | 0.24 € |
| Spread % | 2.81% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
87.68
USD
Average target price
96.31
USD
Spread / Average Target
+9.84%
- Stock Market
- Certificates
- Certificat
